Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Operating Leases (2020 - 2026)

Inspire Medical Systems' Operating Leases history spans 7 years, with the latest figure at $29.6 million for Q1 2026.

  • On a quarterly basis, Operating Leases fell 6.15% to $29.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $29.6 million, a 6.15% decrease, with the full-year FY2025 number at $30.0 million, changed 0.14% from a year prior.
  • Operating Leases hit $29.6 million in Q1 2026 for Inspire Medical Systems, down from $30.0 million in the prior quarter.
  • Over the last five years, Operating Leases for INSP hit a ceiling of $32.6 million in Q3 2025 and a floor of $7.2 million in Q1 2023.
  • Historically, Operating Leases has averaged $21.9 million across 5 years, with a median of $24.8 million in 2023.
  • Biggest five-year swings in Operating Leases: dropped 15.99% in 2023 and later surged 240.99% in 2024.
  • Tracing INSP's Operating Leases over 5 years: stood at $8.9 million in 2022, then surged by 180.05% to $24.8 million in 2023, then grew by 20.9% to $30.0 million in 2024, then decreased by 0.14% to $30.0 million in 2025, then fell by 1.49% to $29.6 million in 2026.
  • Business Quant data shows Operating Leases for INSP at $29.6 million in Q1 2026, $30.0 million in Q4 2025, and $32.6 million in Q3 2025.